Your browser doesn't support javascript.
loading
Genetic analyses of diverse populations improves discovery for complex traits.
Wojcik, Genevieve L; Graff, Mariaelisa; Nishimura, Katherine K; Tao, Ran; Haessler, Jeffrey; Gignoux, Christopher R; Highland, Heather M; Patel, Yesha M; Sorokin, Elena P; Avery, Christy L; Belbin, Gillian M; Bien, Stephanie A; Cheng, Iona; Cullina, Sinead; Hodonsky, Chani J; Hu, Yao; Huckins, Laura M; Jeff, Janina; Justice, Anne E; Kocarnik, Jonathan M; Lim, Unhee; Lin, Bridget M; Lu, Yingchang; Nelson, Sarah C; Park, Sung-Shim L; Poisner, Hannah; Preuss, Michael H; Richard, Melissa A; Schurmann, Claudia; Setiawan, Veronica W; Sockell, Alexandra; Vahi, Karan; Verbanck, Marie; Vishnu, Abhishek; Walker, Ryan W; Young, Kristin L; Zubair, Niha; Acuña-Alonso, Victor; Ambite, Jose Luis; Barnes, Kathleen C; Boerwinkle, Eric; Bottinger, Erwin P; Bustamante, Carlos D; Caberto, Christian; Canizales-Quinteros, Samuel; Conomos, Matthew P; Deelman, Ewa; Do, Ron; Doheny, Kimberly; Fernández-Rhodes, Lindsay.
Afiliação
  • Wojcik GL; Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.
  • Graff M; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Nishimura KK; Division of Public Health Science, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Tao R; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Haessler J; Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Gignoux CR; Division of Public Health Science, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Highland HM; Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.
  • Patel YM; Colorado Center for Personalized Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Sorokin EP; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Avery CL; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Belbin GM; Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.
  • Bien SA; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Cheng I; The Center for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Cullina S; The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Hodonsky CJ; Division of Public Health Science, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Hu Y; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
  • Huckins LM; The Center for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Jeff J; The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Justice AE; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Kocarnik JM; Division of Public Health Science, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Lim U; Pamela Sklar Division of Psychiatric Genomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Lin BM; The Center for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Lu Y; The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Nelson SC; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Park SL; Division of Public Health Science, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Poisner H; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
  • Preuss MH; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Richard MA; The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Schurmann C; Department of Biostatistics, University of Washington, Seattle, WA, USA.
  • Setiawan VW; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Sockell A; The Center for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Vahi K; The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Verbanck M; The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Vishnu A; Brown Foundation Institute for Molecular Medicine, The University of Texas Health Science Center, Houston, TX, USA.
  • Walker RW; The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Young KL; Hasso-Plattner-Institute for Digital Engineering, Digital Health Center, Potsdam, Germany.
  • Zubair N; Hasso-Plattner-Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Acuña-Alonso V; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Ambite JL; Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.
  • Barnes KC; Information Sciences Institute, University of Southern California, Marina del Rey, CA, USA.
  • Boerwinkle E; The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Bottinger EP; The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Bustamante CD; The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Caberto C; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Canizales-Quinteros S; Division of Public Health Science, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Conomos MP; Escuela Nacional de Antropologia e Historia, Mexico City, Mexico.
  • Deelman E; Information Sciences Institute, University of Southern California, Marina del Rey, CA, USA.
  • Do R; Colorado Center for Personalized Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Doheny K; Human Genetics Center, School of Public Health, The University of Texas Health Science Center, Houston, TX, USA.
  • Fernández-Rhodes L; The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nature ; 570(7762): 514-518, 2019 06.
Article em En | MEDLINE | ID: mdl-31217584
ABSTRACT
Genome-wide association studies (GWAS) have laid the foundation for investigations into the biology of complex traits, drug development and clinical guidelines. However, the majority of discovery efforts are based on data from populations of European ancestry1-3. In light of the differential genetic architecture that is known to exist between populations, bias in representation can exacerbate existing disease and healthcare disparities. Critical variants may be missed if they have a low frequency or are completely absent in European populations, especially as the field shifts its attention towards rare variants, which are more likely to be population-specific4-10. Additionally, effect sizes and their derived risk prediction scores derived in one population may not accurately extrapolate to other populations11,12. Here we demonstrate the value of diverse, multi-ethnic participants in large-scale genomic studies. The Population Architecture using Genomics and Epidemiology (PAGE) study conducted a GWAS of 26 clinical and behavioural phenotypes in 49,839 non-European individuals. Using strategies tailored for analysis of multi-ethnic and admixed populations, we describe a framework for analysing diverse populations, identify 27 novel loci and 38 secondary signals at known loci, as well as replicate 1,444 GWAS catalogue associations across these traits. Our data show evidence of effect-size heterogeneity across ancestries for published GWAS associations, substantial benefits for fine-mapping using diverse cohorts and insights into clinical implications. In the United States-where minority populations have a disproportionately higher burden of chronic conditions13-the lack of representation of diverse populations in genetic research will result in inequitable access to precision medicine for those with the highest burden of disease. We strongly advocate for continued, large genome-wide efforts in diverse populations to maximize genetic discovery and reduce health disparities.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hispânico ou Latino / Saúde da Mulher / Herança Multifatorial / População Negra / Povo Asiático / Estudo de Associação Genômica Ampla / Grupos Minoritários Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hispânico ou Latino / Saúde da Mulher / Herança Multifatorial / População Negra / Povo Asiático / Estudo de Associação Genômica Ampla / Grupos Minoritários Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article